147 related articles for article (PubMed ID: 16772925)
1. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function.
Brown DL; Bishop DK; Wood SY; Cederna PS
Plast Reconstr Surg; 2006 Jun; 117(7):2250-8. PubMed ID: 16772925
[TBL] [Abstract][Full Text] [Related]
2. Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts.
Brenner MJ; Tung TH; Mackinnon SE; Myckatyn TM; Hunter DA; Mohanakumar T
Exp Neurol; 2004 Mar; 186(1):59-69. PubMed ID: 14980810
[TBL] [Abstract][Full Text] [Related]
3. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
Tung TH; Mackinnon SE; Mohanakumar T
Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303
[TBL] [Abstract][Full Text] [Related]
4. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
Tung TH; Mackinnon SE; Mohanakumar T
Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
[TBL] [Abstract][Full Text] [Related]
5. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model.
Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA
Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
7. Costimulation blockade in transplantation of nerve allografts: long-term effects.
Kvist M; Kanje M; Ekberg H; Corbascio M; Dahlin LB
J Peripher Nerv Syst; 2008 Sep; 13(3):200-7. PubMed ID: 18844786
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts.
Mungara AK; Brown DL; Bishop DK; Wood SY; Cederna PS
J Reconstr Microsurg; 2008 Apr; 24(3):189-95. PubMed ID: 18459087
[TBL] [Abstract][Full Text] [Related]
9. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD40 ligand antibody permits regeneration through peripheral nerve allografts in a nonhuman primate model.
Brenner MJ; Jensen JN; Lowe JB; Myckatyn TM; Fox IK; Hunter DA; Mohanakumar T; Mackinnon SE
Plast Reconstr Surg; 2004 Dec; 114(7):1802-14; discussion 1815-7. PubMed ID: 15577351
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation by costimulation blockade inhibits rejection of nerve allografts.
Kvist M; Lemplesis V; Kanje M; Ekberg H; Corbascio M; Dahlin LB
J Peripher Nerv Syst; 2007 Jun; 12(2):83-90. PubMed ID: 17565532
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells.
Nathan MJ; Yin D; Eichwald EJ; Bishop DK
Am J Transplant; 2002 Apr; 2(4):323-32. PubMed ID: 12118853
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
15. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation.
Brenner MJ; Mackinnon SE; Rickman SR; Jaramillo A; Tung TH; Hunter DA; Mohanakumar T
Restor Neurol Neurosci; 2005; 23(3-4):237-49. PubMed ID: 16082080
[TBL] [Abstract][Full Text] [Related]
16. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance.
Lal G; Nakayama Y; Sethi A; Singh AK; Burrell BE; Kulkarni N; Brinkman CC; Iwami D; Zhang T; Bromberg JS
Transplantation; 2015 Sep; 99(9):1817-28. PubMed ID: 25839706
[TBL] [Abstract][Full Text] [Related]
18. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
19. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
